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Breast papillomas are one of the most common benign neoplasms in the breast.
Breast papillomas include solitary intraductal papilloma, multiple papillomas,
papillomatosis, and juvenile papillomatosis (JP),1 and they can be single or multiple,
and may or may not be associated with clear or bloodstained nipple discharge.2
They also can be palpable or not. They are difficult to diagnose because of their
symptoms and signs can be confused with those of breast cancer. Patients who
present with atypical nipple discharge routinely undergo mammography with
subsequent galactography. On mammography, papilloma is usually occult,
however, may be visible as a solitary dilated duct, a nodule, or a nonspecific cluster
of microcalcifications.3-6 On sonography, papillomas may be solid, homoge-
neously hypoechoic intraductal mass within a dilated duct.3-6 Galactography may
reveal an intraluminal filling defect, duct diltation, contrast extravasation, or
complete obstruction.3-6 Galactography may reveal and help localize the lesion for
biopsy and may also reveal additional lesions.4,5 Although carcinomas are
frequently encountered, there are no definitive galactographic criteria for differen-
tiation of benign from malignant lesions. Sometimes solitary or multiple papillomas
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Purpose: To evaluate the value of breast MRI in analysis of papillomas of the breast. Materials and Methods:
From 1996 to 2004, 94 patients underwent surgery due to papillomas of the breast. Among them, 21 patients
underwent 3D fast low angle shot (FLASH) dynamic breast MRI. Eight masses were palpable and 11 of 21 patients
had nipple discharge. Two radiologists indifferently analyzed the location, size of the lesions and shape, margin of
the masses, multiplicity and ductal relation. The MRI findings were categorized according to breast imaging
reporting and data system (BI-RADS) lexicon. The amount and pattern of enhancement and associated findings
were also evaluated according to BI-RADS. We then compared the MRI findings with galactography, mam-
mography and breast ultrasonography (US) and examined histopathologic correlation. Results: On breast MRI, the
lesion size was 0.4-1.59 cm, and 18 patients showed subareolar location. On 4.25 cm (mean 1.54) dynamic
enhanced images, imaging findings showed mass (n = 10), intracystic mass (n = 3), focus (n = 5), ductal
enhancement (n = 2), and segmental enhancement (n = 1). In cases of the masses, the shapes of the masses were round
(n = 4), lobulated (n = 3), and irregular (n = 6), and margins were circumscribed (n = 6), microlobulated (n = 5), and
indistinct (n = 2). The enhancement patterns were homogeneous enhancement (n = 7), heterogeneous (n = 3) or rim
enhancement (n = 3). Conclusion: The contrast enhanced dynamic breast MRI was highly sensitive for diagnosis of
breast papillomas. MRI could play a key role in the pre-operative work-up for multiple papillomas and papillomatosis.
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INTRODUCTION
and papillomatosis are difficult to diagnose by imaging
modalities and the role of breast MRI in diagnosis of
mammary lesions has increased.2,7,8 Therefore, the purpose
of this study was to elucidate the role of 3D dynamic
contrast enhanced MRI in the diagnosis and preoperative
evaluation of breast papillomas.
Patients
The institutional review board approved this study and
required neither patients’ approval nor patients’ informed
consent for review of their images and records. From 1996
to 2004, 94 patients were diagnosed with papillomas of the
breast at our institute. Among them, 21 patients had taken
3D fast low angle shot (FLASH) dynamic breast MRI and
those patients were enrolled in this study. All patients were
female, and their age was 27 to 74 years (mean age: 46.3
years). Eleven of 21 patients had nipple discharge, and 2
patients among them showed palpable masses. Eight masses
were palpable and 4 patients were asymptomatic. Three
patients were diagnosed with breast cancer and took  breast
MRI for cancer staging, and another 3 patients took MRI for
screening of high risk patients. Fifteen patients showed
suspicious findings in other imaging modalities. Mammo-
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Fig. 1. A 59-year-old woman with palpable mass at 9 : 00 portion of the right breast. She had no symptom of nipple discharge. (A) Right breast
mammography showing macolobulated nodule at upper outer area (white arrows). Superficial margin of the mass was obscured. (B) Breast
ultrasonography of the mass transverse (1) and longitudinal (2) image revealed isoechoic lobulated mass with some of the margin showing
spiculation. Inferior portion of the mass showed dilated duct (arrow in Fig. 1B-1). The sonographic BI-RADS was category 4a, therefore, US-guided
core biopsy was recommend. (C) Dynamic contrast breast MRI subtraction 1 minute (1), 3 minutes (2), 5 minutes (3) images. The mass showed
lobulated shape, and smooth margin with rim enhancement. Peritumoral delayed enhancement was noted. The kinetics showed persistent
enhancement pattern (4). We concluded BI-RADS category 3. The core biopsy and excision were done, and pathologic result was intraductal
papilloma.
A
graphy was available in 17 patients, and 17 patients took
breast ultrasonography (US), and 8 underwent galacto-
graphy. 
MR imaging
MRI was performed using a 1.5-T magnet (Magnetom
Avanto, Siemens Medical Solution, Erlangen, Germany)
with a dedicated bilateral breast surface coil with prone
position. The imaging protocol and parameters were as
follows: axial T1-weighted image (TR/TE, 500/11) and
T2-weighted turbo spin-echo image (5000/100) of both
breasts were obtained with 3 mm slice thickness. Next, T1-
weighted images were acquired using a 3D FLASH (fast
low-angle shot pulse sequence) with a fat-selective inver-
sion for fat suppression through both breasts (TR/TE
3.91/1.42, flip angle 30O). Precontrast images were obtained
over a 512 ×317 matrix in the axial plane with a slice thick-
ness of 1.5 mm without gap before administration of the
contrast agent. Then, contrast-enhanced dynamic imaging
was performed with an injection of 20 mL of gadopente-
tate dimeglumine (Magnevist, Berlex Laboratories, Wayne,
NJ, USA); five sequential contrast-enhanced images were
aquired at every 1 min. The precontrast images were then
subtracted from the corresponding postcontrast images on
a pixel-by-pixel basis with use of the standard software
subtraction function available on our console. 
MRI examinations were retrospectively reviewed by two
radiologists who experienced in the interpretation of breast
MRI examinations.
Two radiologists independently analyzed the location,
size of lesions, shape, margin of masses, multiplicity and
ductal relation. The MRI findings were described accord-
ing to ACR BI-RADS lexicon and categorized. The amount
and pattern of enhancement and associated findings were
also evaluated. We compared the MRI findings with
galactography, mammography and breast US and examined
histopathologic correlation. The US-guided core biopsy
was performed using 14G automated guns (Bard-Magnum
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Fig. 2. A 47-year-old woman who had bloody nipple discharge from her left breast for 3 months. (A) Cranial caudal (CC) view of mammography
showed heterogeneous dense parenchyma without mass or calcifications. The BI-RADS category was 1, negative finding. (B) Galactography
done at left nipple duct revealed intraductal filling defect, and distal portion was not visible (1, white arrows). After injection of more contrast,
galactography showed multifocal lobulated filling defects (2, white arrows). (C) Ultrasonography showed focal duct prominency and 0.8 ×0.4 cm
sized oval shaped circumscribed nodule with parallel orientation (white arrows), suggesting BI-RADS category 3. (D) Dynamic contrast breast MRI
subtraction 1 minute (1), 3 minutes (2), and 5 minutes (3) images demonstrated segmental heterogeneous enhancement. The kinetics showed
plateau enhancement pattern (4). We concluded BI-RADS category 4a. Excisional biopsy pathologic result was papillomatosis.
A C
Biopsy Instruments, Covington, GA, USA). At least three
good cores of tissue were obtained for each lesion. BI-RADS
category on mammography, sonography, MRI and MRI
kinetics were correlated with pathologic findings and nipple
discharge. All statistical analysis was performed using
SPSS version 11.0 software. All results with a p value of
less than 0.05 were considered significant.
On breast MRI, the lesion size was 0.4 to 4.25 cm (mean
1.54 ± 1.59). On dynamic enhanced images, imaging find-
ings included mass (n = 10), intracystic mass (n = 3), focus
(n = 5), ductal enhancement (n = 2), and segmental enhance-
ment (n = 1). In case of the masses, the shapes of the
masses were round (n = 4), lobulated (n = 3), and irregular
(n = 6) and margins were circumscribed (n = 6), microlo-
bulated (n = 5), and indistinct (n = 2). The enhancement
patterns of the mass and intracystic mass were homo-
geneous enhancement (n = 7), heterogeneous (n = 3) or rim
enhancement (n = 3). Four cases among mass enhance-
ment had multiple lesions which showed multiple nodular
enhancements. Their pathology of those multiple enhanced
nodules was papillomas (n = 2), intraductal papilloma with
atypical lobular hyperplasia (n = 1) and papillomatsis (n = 1).
In terms of non-mass like enhancement, 2 cases showed
ductal enhancement and 1 case revealed segmental enhan-
cement. Two cases of ductal enhancement revealed 1 intra-
ductal papilloma and 1 papillomatosis, while segmental
Diagnostic Value of 3D FLASH Dynamic MRI of Breast Papillomas 
Yonsei Med J   http://www.eymj.org    Volume 50   Number 6   December 2009 841
RESULTS
A-1 A-2 B-2 C
B-1
D-1
D-2
D-3 D-4
Fig. 3. A 39-year-old woman presented with bloody nipple discharge on her left breast. (A) Left mammography, MLO (1) and CC (2) view showed
heterogeneous dense parenchyma pattern and well-circumscribed high density mass lesion at left upper outer portion of breast (white arrow). No
evidence of microcalcifications. (B) Breast ultrasonography (a) showed 2.0 ×1.7 cm sized mass lesion at left 2 : 00 portion. The mass was complex
cystic mass with internal lobulated hypoechoic solid lesion. Focal ductal extenstion toward the nipple was noted (white arrows). On Doppler image,
peripheral increased blood flow was seen. There was no blood flow within the mass (b). (C) On galactography, dilated nipple duct was noted and
contrast dye which filled the cystic portion of the mass lesion and solid lesion demonstrated to be lobulated filling defect. (D) Dynamic contrast
breast MRI subtraction 1 minute (1), 3 minutes (2), and 5 minutes (3) images. The mass lesion at left 2 : 00 showed peripheral thin rim enhancement.
The solid portion of the mass did not reveal enhancement in dynamic images. The enhancement kinetics demonstrated persistent pattern (4),
therefore, the BI-RADS category was 3. The pathologic result after excision was intraductal papilloma.
enhanced lesion was papillomatosis. Those 2 cases of
ductal enhancement indicated negative findings in US.
After taken breast MRI, the treatment plans for papillary
lesions were changed in 5 patients. The kinetic curve of
initial phase showed fast enhancement in all cases, and
persistent (n = 15), plateau (n = 5), and wash out pattern (n
= 1) in delayed phase. In terms of MR kinetics, the lesions
with persistent enhancement pattern (n = 15) revealed intra-
ductal papilloma in 12 cases (80%), 1 papillomas, 1 intra-
ductal papilloma with microcalcifications and 1 papillo-
matosis with microcalcifications. Otherwise, the lesions
with plateau pattern enhancement showed 2 intraductal
papilloma, 2 papillomatosis and 1 intraductal papiloma
with atypical lobular hyperplasia. Overall, BI-RADS
categories of breast MRI were 3 (n = 14), 4a (n = 6), and
category 4b (n = 1). Among the 14 lesions diagnosed with
BI-RADS 3, their final pathologies were: intraductal
papilloma (n = 12, 85.7%), papillomas (n = 1) and papil-
lomatosis with microcalcifications (n=1). On BI-RADS,
category 4a lesions were: intraductal papilloma (n = 3),
papillomatosis (n = 2) and intraductal papilloma with
atypical lobular hyperplasia (n = 1). On pathologic evalua-
tions, the lesion size was 0.3 to 3.83 cm, suggesting mild
overestimation of lesion size in MRI study.
Mammography was performed on 17 cases, and the
findings were: negative (n = 4), mass (n = 6), asymmetric
density (n = 4), and microcalcifications (n = 3). The mass
density revealed well-defined high density mass (n = 6),
multiple nodular densities (n = 1), and speculated irregular
shaped mass (n = 1). The BI-RADS category of mammo-
graphy was category 1 (n = 4), 3 (n = 4), 4a (n = 1), 4b (n =
2) and 0 (n=6).
On breast ultrasonography (n = 17), the findings were:
mass (n = 11), duct dilatation (n = 3), ill-defined hetero-
geneous echo (n = 1), and negative findings (n = 2). The
mass lesion showed solid (n = 8) or intracystic mass (n = 3),
and 3 cases among them showed multiple masses. US BI-
RADS categories were category 1 (n = 2), 3 (n = 9), 4a (n
= 3), and 4b (n = 3).
On galactography, the findings were: single filling defect
(n = 4) and multiple filling defects (n = 4).
US-guided core biopsy was performed when possible (n
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Table 1. The Radiological Findings of Papillomas in the Breast
No Age
Nipple 
Palpable
Mammography US
Galactography
MRI MR 
Pathology
discharge BI-RADS BI-RADS BI-RADS kinetics
1 60 Bloody 3 3 + 3 1 IDP
2 74 - 3 3 3 1 Papillomas
3 47 Bloody 1 3 ++ 4a 2 Papillomastosis
4 42 Serous + 3 3 4a 2 IDP with ALH
5 32 - + 3 ++ 3 1 IDP
6 50 Serous 3 1 IDP
7 42 Bloody 1 4a 2 IDP
8 49 Bloody 3 1 IDP
9 51 - 1 3 3 1 IDP
10 51 - + 4a 4a 4a 2
Papillomatosis 
with microca
11 47 Bloody 3 3 + 3 1 IDP
12 59 - + 0 4a 3 1 IDP
13 48 - 0 3 + 3 1 IDP
14 40 - + 4b 4b 4a 1 IDP with microca
15 41 - + 0 3 3 1 IDP
16 27 - + 4b 4b 3 1
Papillomatosis 
with microca
17 35 Bloody 0 4b ++ 4b 3 IDP
18 39 Bloody + 0 4a ++ 3 1 IDP
19 46 Serous 1 1 3 1 IDP
20 43 Serous 0 + 3 1 IDP
21 50 - 1 4a 2 IDP
Galactography: +, single filling defect; ++, multiple filling defect; ++, MR kinetics: 1, persistent; 2, plateau; 3, wash out. IDP, Intraductal papilloma; Microca,
microcalcifications. US, ultrasonography; BI-RADS, breast imaging reporting and data system; ALH, atypical lobular hyperplasia.
= 7), and another surgical biopsies such as mammo-guided
(n = 2) or US-guided (n = 5) localization excision were done.
In case of MR showing only lesion with persistent nipple
discharge, intraoperative ductography guided (n = 4) exci-
sion were performed. According to statistical analysis, the
nipple discharge was not correlated with BI-RADS of
imaging modalities and breast MRI kinetics (p > .05)
The imaging findings and BI-RADS categories are listed
in Table 1.
Breast papillomas are a variety of lesions in the breast that
are characterized by a papillary configuration on gross or
microscopic examination. These include solitary intraduc-
tal papillomas, multiple papillomas, papillomatosis, and
juvenile papillomatosis.1 Solitary intraductal papillomas
are tumors of major lactiferous ducts, common cause of a
serous or serosanguinous nipple discharge. Papilloma is
the most common pathologic finding in women with
pathologic nipple discharge, accounting for 40% to 70% of
cases.9 Multiple intraductal papillomas tend to occur in
younger patients, are less often associated with nipple
discharge, more frequently peripheral and more often
bilateral. Essentially, these lesions appear to be susceptible
to the development of carcinoma.10 Carter, et al.11 reported
that 2 of 6 patients with multiple papillomas developed
cancer, while only 4 of 58 patients with solitary papilloma
developed cancer. Another report found that 5 of 51
patients with multiple papillomas developed cancer, which
is in marked contrast to 4 of 174 developed cancers with a
solitary papilloma. In this series, 32% of simultaneous or
subsequent cancers with multiple papillomas were apocrine
papillary and cribriform types.12 Papillomatosis is a term
used to describe microscopic foci of intraductal hyper-
plasia, which have papillary architecture without atypia.13 
The imaging findings of breast papillomas are very
variable, and its pathology is also difficult to diagnose.
Breast papillomas are one of the most difficult diagnostic
and therapeutic problems, and they could be histologically
benign, borderline, or malignant.
On conventional mammography, intraductal papilloma
could not be detected, and it has a postitive predictive value
of only 25%. The sensitivity is particularly low in young
women who have dense breast.14 In our cases, the mammo-
graphic findings were negative in 4 cases. We could detect
positive mammographic findings in 13 cases among 17
patients: it is because it was diagnostic setting, therefore,
the sensitivity was higher than screening setting. In case of
microcalcifications, the morphology and distribution reveal-
ed suspicious findings. Therefore, so even if other imaging
modality showed probable benign findings, further inves-
tigations were required. 
The galactography is a traditional method for evaluation
of the affected duct system in patients with nipple discharge.
It is painful and invasive method, and has some complica-
tions which include perforation of duct, extravasations of
contrast material, and mastitis. These days, therefore, the
galactography was replaced by ultrasonography in most of
breast centers. Breast papillomas can be demonstrated by
filling defects within the dilated duct on galactography.
Distortion, narrowing or obstruction of the ducts may indi-
cate malignancy.1 We had 8 cases of galactography in
breast papillomas, which showed filling defects or narrow-
ing of duct. However, galactography is a painful procedure
and has difficulties in differential diagnosis of benign
versus malignancy. 
Recently, high resolution ultrasonography is helpful in
visualizing intraductal disorders and is becoming a method
complementary to traditional radiology techniques.15 How-
ever, the sonographic findings of papillomas are variable,
and a recent study revealed that sonography is not able to
predict malignancy and its positive predictive value is 75%.
In our study, the sonographic diagnoses were diverse, and
US BI-RADS were 3 to 4b. If patients have nipple discharge
or if there was duct dilatation adjacent to the nodules, those
findings could possibly have made us to diagnose papil-
lomas. Even more, the ultrasound-guided percutaneous
core biopsy and vacuum-assisted large needle biopsy are
reliable diagnostic and minimally invasive therapeutic
modalities for breast papillomas. 
Although MRI is a highly sensitive method for diagnos-
ing breast cancer, its role in the management of papillomas
is still controversial.7,8 According to Kramer, et al.,7 combi-
nation of breast MRI and galactography could not increase
the sensitivity, however, MRI could detect the DCIS which
escaped detection with galactography. Daniel, et al., divided
the MRI findings of papillomas into 3 groups: 1) small
luminal mass papillomas, 2) tumor-like papillomas and 3)
MRI-occult papillomas.8 Three groups showed different
MRI findings and kinetics. In our cases, there was no case
of MRI-occult papilloma. Therefore, the sensitivity of breast
MRI of papillomas was 100%. In terms of mass enhance-
ment, the MRI findings were variable. Six masses showed
irregular shape enhancement and 13 masses revealed
lobulated shape. Therefore, 6 masses among them were
MRI BI-RADS category 4a, and 1 was BI-RADS 4b. In
our results, there were more papillomatosis or high risk
lesions in MRI BI-RADS category 4a than category 3
lesions. If the lesion showed suspicious findings in other
imaging modalities, however, the MRI kinetics of the
masses showed persistent delayed enhancement, thus
making us to consider the possibility of benign mass. There
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DISCUSSION
were more papillomatosis or high risk lesions in plateau
pattern enhancement than persistent. We had another
different pattern of enhancement, such as ductal enhance-
ment or segmental enhancement. Especially, in cases of
clinically, mammographically and sonographycally nega-
tive breast, breast MRI is helpful for lesion detetion and
treatment of nipple discharge. Even there was a mass or
asymmetry in mammography or sonography, MRI could
find more masses than other image modalities.
The limitation of this study was: the sample size was too
small. More samples of papillary lesions of the breasts,
including atypism or papillary carcinoma, are needed. 
In conclusion, breast MRI could detect papillomas of the
breast more than any other image modalities; however its
MRI findings were variable. Especially, in terms of multi-
focal papillomas and papillomatosis, breast MRI plays a
key role for evaluation of disease extent.
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